COL6 Fund

COL6 Fund is a venture philanthropy organization dedicated to accelerating the development of treatments and a cure for Collagen VI-related dystrophies (COL6-RD), including Ullrich congenital muscular dystrophy and Bethlem myopathy. The fund operates by identifying high-potential research projects and providing the necessary capital and strategic guidance to move them toward clinical trials. By bridging the gap between academic discovery and commercial drug development, COL6 Fund aims to de-risk early-stage programs to attract larger biotech and pharmaceutical partners. Their portfolio includes diverse approaches such as gene editing, gene replacement, and small molecule therapies targeting the underlying genetic causes of collagen deficiency.